Media Pack
News

Current Edition

Volume 16 Issue 3
 
 
Going All-in on ePRO
Special Features

Going All-in on ePRO

The growing complexity of clinical trials has fuelled demand for ePRO solutions that ease the burden of trial participation for patients while building confidence in ...
24 February 2016 Special Features | Special Features V8 I1
Continue Reading →
BYOD, ePRO and Unified Data Management Solutions
Special Features

BYOD, ePRO and Unified Data Management Solutions

This article will examine the other advantages of having a unified data management solution. BYOD and ePRO certainly benefit from this, but it does not stop there; ha...
24 February 2016 Special Features | Special Features V8 I1
Continue Reading →
Clinical Trial Logistics: GCP as an Obstacle Rather than a Support?
Special Features

Clinical Trial Logistics: GCP as an Obstacle Rather than a Support?

Within the following white paper Dr Wolfgang Eglmeier, Head, Center for Clinical Trials, Witten/Herdecke University, looks into clinical trials information – from the...
24 February 2016 Special Features | Special Features V8 I1
Continue Reading →
Precision Power Helps Drive the Drug Development Process for Speciality Medicines
Special Features

Precision Power Helps Drive the Drug Development Process for Speciality Medicines

Innovation is the ultimate engine of growth for the global provision of medicines. Speed to market through faster drug development processes is continually in demand,...
24 February 2016 Special Features | Special Features V8 I1
Continue Reading →
Going All-in on ePro
Special Features

Going All-in on ePro

The growing complexity of clinical trials has fuelled demand for ePRO solutions that ease the burden of trial participation for patients while building confidence in ...
23 February 2016 Special Features | Special Features V8 I1
Continue Reading →
Assay Sensitivity in QT Assessment
Special Features

Assay Sensitivity in QT Assessment

The TQT study, since its implementation in 2005, has been a target for criticism due to the increased cost of drug development. For the last 10 years, more efficie...
12 January 2016 Special Features
Continue Reading →
Evolution of the Proarrhythmic Cardiac Safety Regulatory Landscape: The Likely Revision of ICH Guideline E14 and its Consequences
Special Features

Evolution of the Proarrhythmic Cardiac Safety Regulatory Landscape: The Likely Revision of ICH Guideline E14 and its Consequences

Since its release 10 years ago, ICH Guideline E14 has governed the clinical proarrhythmic cardiac safety regulatory landscape: it has been adopted by the United St...
12 January 2016 Special Features
Continue Reading →
 
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte